AU6400600A - Improvements in antisense oligomers, delivery of antisense oligomers, and identification of antisense oligomer targets - Google Patents

Improvements in antisense oligomers, delivery of antisense oligomers, and identification of antisense oligomer targets

Info

Publication number
AU6400600A
AU6400600A AU64006/00A AU6400600A AU6400600A AU 6400600 A AU6400600 A AU 6400600A AU 64006/00 A AU64006/00 A AU 64006/00A AU 6400600 A AU6400600 A AU 6400600A AU 6400600 A AU6400600 A AU 6400600A
Authority
AU
Australia
Prior art keywords
antisense
oligomers
antisense oligomers
delivery
identification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU64006/00A
Inventor
Terry B. Beck
Tod M. Woolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Life Technologies Corp
Trilink Biotechnologies LLC
Original Assignee
Sequitur Inc
Trilink Biotechnologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sequitur Inc, Trilink Biotechnologies LLC filed Critical Sequitur Inc
Publication of AU6400600A publication Critical patent/AU6400600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/321—2'-O-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/33—Chemical structure of the base
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/34—Spatial arrangement of the modifications
    • C12N2310/346—Spatial arrangement of the modifications having a combination of backbone and sugar modifications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU64006/00A 1999-08-03 2000-08-03 Improvements in antisense oligomers, delivery of antisense oligomers, and identification of antisense oligomer targets Abandoned AU6400600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14685799P 1999-08-03 1999-08-03
US60146857 1999-08-03
PCT/US2000/021444 WO2001009312A2 (en) 1999-08-03 2000-08-03 Improvements in antisense oligomers, delivery of antisense oligomers, and identification of antisense oligomer targets

Publications (1)

Publication Number Publication Date
AU6400600A true AU6400600A (en) 2001-02-19

Family

ID=22519283

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64006/00A Abandoned AU6400600A (en) 1999-08-03 2000-08-03 Improvements in antisense oligomers, delivery of antisense oligomers, and identification of antisense oligomer targets

Country Status (3)

Country Link
EP (1) EP1206532A2 (en)
AU (1) AU6400600A (en)
WO (1) WO2001009312A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100468316B1 (en) 2002-01-29 2005-01-27 주식회사 웰진 Peptides increasing the transfer efficiency of DNA into cell or tissue
BR112020013848A2 (en) 2018-01-08 2020-12-01 Iovance Biotherapeutics, Inc. methods for expanding tumor-infiltrating lymphocytes and for treating an individual with cancer, tumor-infiltrating lymphocyte population, and, method for evaluating transcription factors
WO2019136459A1 (en) 2018-01-08 2019-07-11 Iovance Biotherapeutics, Inc. Processes for generating til products enriched for tumor antigen-specific t-cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614621A (en) * 1993-07-29 1997-03-25 Isis Pharmaceuticals, Inc. Process for preparing oligonucleotides using silyl-containing diamino phosphorous reagents

Also Published As

Publication number Publication date
WO2001009312A3 (en) 2001-10-04
EP1206532A2 (en) 2002-05-22
WO2001009312A2 (en) 2001-02-08

Similar Documents

Publication Publication Date Title
AU2740997A (en) Slow-release, self-absorbing, drug delivery system
AU1719800A (en) Drug delivery systems and methods
AU2001243361A1 (en) Package delivery notification system and method
AU1329901A (en) System for item and orientation identification
AU2002241952A1 (en) Cell-proliferative disorder treatments using cre decoy oligomers, bcl-2 antisense and hybrid oligomers
AU2001264639A1 (en) Package delivery systems and methods
AU2513400A (en) Authentication system and process
MXPA02001857A (en) Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties.
AU1493101A (en) Portable beverage delivery system
AUPQ321699A0 (en) Gaming security system
AU2001280125A1 (en) Card payment method and card payment system for door-to-door delivery
AU1874397A (en) Hexitol containing oligonucleotides and their use in antisense strategies
AU3764899A (en) High molecular weight polyols, process for preparation and use thereof
ZA200203525B (en) Transdermal contraceptive delivery system and process.
EP1208234A4 (en) Poly(ether-thioether), poly(ether-sulfoxide) and poly(ether-sulfone) nucleic acids
AU7316800A (en) Physical strength enhancing agents and glycogen accumulation promoting agents
AU7748200A (en) Hypoxia-related human genes, proteins, and uses thereof
PL341275A1 (en) Protective feature and card incorporating such protective feature
AU6400600A (en) Improvements in antisense oligomers, delivery of antisense oligomers, and identification of antisense oligomer targets
AU5685800A (en) Identification and overexpression of a dna sequence coding for 2-methyl-6-phytylhydroquinone-methyltransferase in plants
EP1224704A4 (en) Energy production, storage and delivery system
AU4225200A (en) Improved antisense oligomers
AU5607500A (en) System and method for promising delivery of configured products
AU1979001A (en) Cryptographic token and security system
AU5744900A (en) Food distribution, preparation and consumption system

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase